These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9030228)

  • 1. [Development of anti tumor agents targeting angiogenesis].
    Ono M; Kuwano M
    Gan To Kagaku Ryoho; 1997 Jan; 24(2):178-86. PubMed ID: 9030228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis research enjoys growth spurt in the 1990s.
    Ziegler J
    J Natl Cancer Inst; 1996 Jun; 88(12):786-8. PubMed ID: 8637041
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neovascularization and tumor development].
    Ono M; Kuwano M
    Nihon Naika Gakkai Zasshi; 1998 Aug; 87(8):1577-87. PubMed ID: 9780690
    [No Abstract]   [Full Text] [Related]  

  • 4. Vascular targeting and the inhibition of angiogenesis.
    Bicknell R
    Ann Oncol; 1994; 5 Suppl 4():45-50. PubMed ID: 7520262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of angiogenesis.
    Folkman J; Ingber D
    Semin Cancer Biol; 1992 Apr; 3(2):89-96. PubMed ID: 1378314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Angiogenesis and its inhibitors].
    Ono M; Kuwano M
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1585-93. PubMed ID: 9309158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antiangiogenic agents on experimental animal models of hepatocellular carcinoma.
    Qin LX; Tang ZY; Li XM; Bu W; Xia JL
    Ann Acad Med Singap; 1999 Jan; 28(1):147-51. PubMed ID: 10374041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-angiogenesis in cancer therapy.
    Muehlbauer PM
    Semin Oncol Nurs; 2003 Aug; 19(3):180-92. PubMed ID: 12962008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice.
    Bergers G; Javaherian K; Lo KM; Folkman J; Hanahan D
    Science; 1999 Apr; 284(5415):808-12. PubMed ID: 10221914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent progress in the development of anti-tumor metastatic drugs].
    Kumagai H
    Gan To Kagaku Ryoho; 1995 Apr; 22(5):585-91. PubMed ID: 7536403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor.
    Maquoi E; Sounni NE; Devy L; Olivier F; Frankenne F; Krell HW; Grams F; Foidart JM; Noël A
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4038-47. PubMed ID: 15217936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiated antitumor effects of interleukin 12 and matrix metalloproteinase inhibitor batimastat against B16F10 melanoma in mice.
    Dabrowska A; Giermasz A; Marczak M; Gołab J; Jakóbisiak M
    Anticancer Res; 2000; 20(1A):391-4. PubMed ID: 10769685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's amyloid precursor protein alpha-secretase is inhibited by hydroxamic acid-based zinc metalloprotease inhibitors: similarities to the angiotensin converting enzyme secretase.
    Parvathy S; Hussain I; Karran EH; Turner AJ; Hooper NM
    Biochemistry; 1998 Feb; 37(6):1680-5. PubMed ID: 9484239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Control of tumor-related angiogenesis].
    Oikawa T
    Hum Cell; 1998 Dec; 11(4):201-6. PubMed ID: 10363157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tumor angiogenesis.
    Sipos EP; Tamargo RJ; Weingart JD; Brem H
    Ann N Y Acad Sci; 1994 Sep; 732():263-72. PubMed ID: 7526758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Angiogenesis research--quo vadis?].
    Augustin HG
    Ophthalmologe; 2003 Feb; 100(2):104-10. PubMed ID: 12589453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant platelet factor 4: a therapeutic, anti-neoplastic chimera?
    Lippi G; Favaloro EJ
    Semin Thromb Hemost; 2010 Jul; 36(5):558-69. PubMed ID: 20632253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of thalidomide to inhibit tumor growth and angiogenesis in vivo.
    Gutman M; Szold A; Ravid A; Lazauskas T; Merimsky O; Klausner JM
    Anticancer Res; 1996; 16(6B):3673-7. PubMed ID: 9042240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor vasculature as target for therapeutic intervention.
    Fens MH; Storm G; Schiffelers RM
    Expert Opin Investig Drugs; 2010 Nov; 19(11):1321-38. PubMed ID: 20946091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.